Pfizer and Lilly announce top-line results of Tanezumab

Drug Discovery |  News | 0 Comment | 31 Jan, 2019

Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg i...Read more

J&J announces USFDA approval of IMBRUVICA

Drug Discovery |  News | 0 Comment | 29 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...Read more

Basilea announces collaboration with Roche

Drug Discovery |  News | 0 Comment | 25 Jan, 2019

Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche ...Read more

Wren Therapeutics completes £18M Series A Financing

Drug Discovery |  News | 0 Comment | 23 Jan, 2019

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases ...Read more

AbbVie provides update on Phase 3 Study of IMBRUVICA

Drug Discovery |  News | 0 Comment | 22 Jan, 2019

AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-113...Read more

Everest Medicines signs new deal targeting drug resistance

Drug Discovery |  News | 0 Comment | 14 Jan, 2019

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...Read more

Janssen submits application to EMA seeking approval of STELARA

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation ...Read more

Denali Therapeutics announces Phase 1B Study of DNL747

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurode...Read more

Japan approves Amgen's osteoporosis drug

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...Read more

Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Drug Discovery |  News | 0 Comment | 09 Jan, 2019

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and s...Read more

Oculis raises CHF 15.5 million

Drug Discovery |  News | 0 Comment | 08 Jan, 2019

Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently ...Read more

AbbVie and Tizona Therapeutics announce strategic collaboration

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, s...Read more

Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for&n...Read more

AstraZeneca announces phase III trials for roxadustat

Drug Discovery |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...Read more

Lupin gets FDA approval for Clobazam oral suspension

Drug Discovery |  News | 0 Comment | 01 Jan, 2019

Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United S...Read more

Teva brings Generic Elidel Cream, 1% in US market

Drug Discovery |  News | 0 Comment | 01 Jan, 2019

Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus)...Read more

BeiGene initiates clinical trial of Tislelizumab with cancer patients

Drug Discovery |  News | 0 Comment | 31 Dec, 2018

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...Read more